Back to search

Article

Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines

2020-01-29

Abstract excerpt

Starting from December 2019, a novel coronavirus, named 2019-nCoV, was found to cause Severe Acute Respiratory (SARI) symptoms and rapid pandemic in China. With the hope to identify candidate drugs for 2019-nCoV, we adopted a computational approach to screen for available commercial medicines which may function as inhibitors for the M pro of 2019-nCoV. Up to 10 commercial medicines that may form hydrogen bounds t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e7b15717-b319-5ff6-801c-2f858e60b559
DOI
10.1101/2020.01.29.924100
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Select a neighboring publication to make it the new centre.